 Lisa Korn
Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 1 | 2024 | 164 | 0.710 |
Why?
| | Intestines | 2 | 2014 | 354 | 0.410 |
Why?
| | Interleukins | 2 | 2014 | 248 | 0.410 |
Why?
| | Lymphocytes | 2 | 2024 | 376 | 0.390 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2014 | 364 | 0.380 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2021 | 1146 | 0.380 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2014 | 411 | 0.360 |
Why?
| | Intestinal Mucosa | 1 | 2014 | 675 | 0.280 |
Why?
| | Immunity, Innate | 1 | 2014 | 835 | 0.260 |
Why?
| | Food Intolerance | 1 | 2024 | 3 | 0.210 |
Why?
| | Food | 1 | 2024 | 150 | 0.190 |
Why?
| | Bone Marrow | 1 | 2024 | 307 | 0.180 |
Why?
| | Dimethyl Fumarate | 1 | 2021 | 12 | 0.180 |
Why?
| | Eosinophils | 1 | 2024 | 316 | 0.170 |
Why?
| | Antioxidants | 1 | 2021 | 550 | 0.130 |
Why?
| | Immunosuppressive Agents | 2 | 2021 | 838 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 289 | 0.130 |
Why?
| | Autoimmunity | 1 | 2021 | 933 | 0.110 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 923 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 391 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 384 | 0.110 |
Why?
| | Animals | 6 | 2024 | 38102 | 0.100 |
Why?
| | Antiviral Agents | 1 | 2020 | 769 | 0.100 |
Why?
| | Genes, RAG-1 | 1 | 2014 | 11 | 0.100 |
Why?
| | Lung Diseases, Interstitial | 1 | 2020 | 664 | 0.100 |
Why?
| | Germinal Center | 1 | 2014 | 64 | 0.100 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1752 | 0.100 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2014 | 81 | 0.100 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2014 | 132 | 0.100 |
Why?
| | Antigen Presentation | 1 | 2014 | 208 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2014 | 167 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2014 | 385 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2014 | 3130 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2191 | 0.070 |
Why?
| | B-Lymphocytes | 1 | 2014 | 872 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2014 | 2050 | 0.060 |
Why?
| | Mice | 4 | 2021 | 18356 | 0.050 |
Why?
| | Tretinoin | 1 | 2024 | 125 | 0.050 |
Why?
| | Intestine, Small | 1 | 2024 | 167 | 0.050 |
Why?
| | Skin Ulcer | 1 | 2020 | 15 | 0.040 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2020 | 19 | 0.040 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 83 | 0.040 |
Why?
| | Exanthema | 1 | 2020 | 86 | 0.040 |
Why?
| | Calcium | 1 | 2005 | 1191 | 0.040 |
Why?
| | Humans | 5 | 2024 | 145783 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2005 | 1998 | 0.030 |
Why?
| | Female | 3 | 2021 | 79045 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5993 | 0.030 |
Why?
| | H-2 Antigens | 1 | 2014 | 111 | 0.030 |
Why?
| | Hypoxia | 1 | 2020 | 1199 | 0.020 |
Why?
| | Autoantibodies | 1 | 2020 | 1509 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2865 | 0.020 |
Why?
| | Antigens | 1 | 2014 | 348 | 0.020 |
Why?
| | Immunization | 1 | 2014 | 375 | 0.020 |
Why?
| | Virus Diseases | 1 | 2014 | 216 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1711 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 6033 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2014 | 501 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7134 | 0.020 |
Why?
| | Middle Aged | 2 | 2021 | 36309 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2020 | 2668 | 0.020 |
Why?
| | Ionophores | 1 | 2005 | 24 | 0.010 |
Why?
| | Deoxyribonuclease I | 1 | 2005 | 41 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2005 | 157 | 0.010 |
Why?
| | Luciferases | 1 | 2005 | 154 | 0.010 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2005 | 139 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2005 | 94 | 0.010 |
Why?
| | CD4 Antigens | 1 | 2005 | 137 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14254 | 0.010 |
Why?
| | Cyclosporine | 1 | 2005 | 256 | 0.010 |
Why?
| | Species Specificity | 1 | 2005 | 546 | 0.010 |
Why?
| | Tacrolimus | 1 | 2005 | 196 | 0.010 |
Why?
| | Interleukin-2 | 1 | 2005 | 440 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 979 | 0.010 |
Why?
| | Models, Genetic | 1 | 2005 | 527 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1311 | 0.010 |
Why?
| | Base Sequence | 1 | 2005 | 2171 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2005 | 673 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 2883 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2005 | 1247 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2005 | 740 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 2240 | 0.010 |
Why?
| | RNA | 1 | 2005 | 912 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1454 | 0.010 |
Why?
| | Adult | 1 | 2021 | 40881 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1482 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2005 | 3551 | 0.010 |
Why?
| | Transcription Factors | 1 | 2005 | 1736 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2601 | 0.010 |
Why?
| | Male | 1 | 2021 | 73011 | 0.010 |
Why?
|
|
Korn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|